KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Short-term Investments (2016 - 2026)

Supernus Pharmaceuticals has reported Short-term Investments over the past 14 years, most recently at $180.2 million for Q4 2025.

  • Quarterly Short-term Investments fell 53.1% to $180.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $180.2 million through Dec 2025, down 53.1% year-over-year, with the annual reading at $180.2 million for FY2025, 53.1% down from the prior year.
  • Short-term Investments was $180.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $129.8 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $384.3 million in Q4 2024 and troughed at $105.2 million in Q3 2023.
  • The 5-year median for Short-term Investments is $191.9 million (2022), against an average of $231.1 million.
  • Year-over-year, Short-term Investments skyrocketed 253.16% in 2024 and then plummeted 65.07% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $136.2 million in 2021, then soared by 170.26% to $368.2 million in 2022, then crashed by 51.16% to $179.8 million in 2023, then soared by 113.7% to $384.3 million in 2024, then tumbled by 53.1% to $180.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Short-term Investments are $180.2 million (Q4 2025), $129.8 million (Q3 2025), and $377.9 million (Q2 2025).